FDA.reportPublic FDA data

fezolinetant 45 MG Oral Tablet [Veozah]

RxCUI
2637147
RxNorm name
fezolinetant 45 MG Oral Tablet [Veozah]
Display name
fezolinetant 45 MG Oral Tablet [Veozah]
Full name
fezolinetant 45 MG Oral Tablet [Veozah]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:21

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VEOZAHFEZOLINETANTAstellas Pharma US, Inc.cae9f798-24f9-4580-a4fc-e6c710cbda3c2026-02-26Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2637147

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
cae9f798-24f9-4580-a4fc-e6c710cbda3cVEOZAH 45 MG Oral Tablet [PSN] · fezolinetant 45 MG Oral Tablet [Veozah] [SBD] · Veozah 45 MG Oral Tablet [SY]38These highlights do not include all the information needed to use VEOZAH safely and effectively. See full prescribing information for VEOZAH. VEOZAH ® (fezolinetant) tablets, for oral use Initial U.S. Approval: 202320260226